Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy.

Ryusuke NakamotoLisa C ZabaJarrett RosenbergSunil Arani ReddyTomomi W NobashiValentina FerriGuido DavidzonCarina Mari ApariciJudy NguyenFarshad MoradiAndrei IagaruBenjamin Lewis Franc

Published in: Molecular imaging and biology (2020)

Patients at high risk of developing HPD could not be accurately identified based on baseline PET/CT parameters. The ratios of baseline and first restaging PET/CT parameters may be helpful to diagnose HPD, when patients do not undergo pre-baseline imaging.

Keyphrases

pet ct
positron emission tomography
high resolution
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
type diabetes
computed tomography
metabolic syndrome
blood pressure
adipose tissue
blood glucose
patient reported
weight loss